Trial Search Results
Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy.
Stanford is currently accepting patients for this trial.
Collaborator: The University of Texas Health Science Center at San Antonio
- Behavioral: CPT-Text
- Behavioral: Culturally Informed Trauma Treatment (CITT)
- Behavioral: Retention Incentive
- Behavioral: Reminder as Usual
- Over the age of 18 residing in the United States; Criterion A event measured by the
Life Events Checklist for DSM-5 (LEC-5); and significant symptoms of PTSD as evidenced
by a score of 33 or above on the PCL-5; PTSD symptoms that began or increased during
the COVID pandemic (per self-report); registered/registering on Talkspace for
messaging-based therapy and ownership of a personal device for texting. In a state
with therapist capacity on the Talkspace platform
- (1) acute risk for suicidal thoughts and/or behaviors measured by the Columbia Suicide
Severity Rating Scale Lifetime-Recent Screen, and (2) psychosis or substance abuse
that requires prioritization of treatment and/or higher level of care.
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study